Legend Biotech (LEGN) Non-Current Deferred Tax Liability (2019 - 2021)

Legend Biotech (LEGN) has 3 years of Non-Current Deferred Tax Liability data on file, last reported at $22.8 million in Q4 2021.

• In Q4 2021, Non-Current Deferred Tax Liability fell 35.05% year-over-year to $22.8 million; the TTM figure through Dec 2021 stood at $22.8 million (down 35.05% YoY), while the FY2021 annual figure was $22.8 million, down 35.05% from the prior year.
• Non-Current Deferred Tax Liability slipped to $22.8 million in Q4 2021, from $35.0 million in the prior quarter.
• Across five years, Non-Current Deferred Tax Liability topped out at $47.7 million in Q4 2019 and bottomed at $22.8 million in Q4 2021.
• A 3-year average of $35.2 million and a median of $35.0 million in 2020 frame the typical range for Non-Current Deferred Tax Liability.
• Annual changes were most pronounced in 2020 — Non-Current Deferred Tax Liability retreated 26.54% — and 2021, when it plunged 35.05%.
• Year by year, Non-Current Deferred Tax Liability stood at $47.7 million in 2019, then retreated by 26.54% to $35.0 million in 2020, then plunged by 35.05% to $22.8 million in 2021.
• The last three Non-Current Deferred Tax Liability figures came in at $22.8 million (Q4 2021), $35.0 million (Q4 2020), and $47.7 million (Q4 2019), per Business Quant data.

Peer Comparison